CLINICAL_TRIALS
ClinicalTrials.gov record update
Clinical Follow-up Study of CD19 CAR-T Expressing IL7 and CCL19 for Relapsed or Refractory B Cell Lymphoma
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT04833504
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:27:35.589762+00:00
- Published At
- 2025-07-16T00:00:00+00:00
- Record Updated At
- 2025-07-16
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Diffuse Large B-cell Lymphoma", "Mantle Cell Lymphoma", "Transformed Follicular Lymphoma", "Primary Mediastinal Large B-cell Lymphoma"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-07-16"- protocolSection.identificationModule.nctId
"NCT04833504"- protocolSection.identificationModule.officialTitle
"Clinical Follow-up Study of CD19 CAR-T Expressing IL7 and CCL19 for Relapsed or Refractory B Cell Lymphoma"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
[]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.